The FDA has issued a warning that Percocet and eight other opiod products packaged by Novartis may have been mixed up. Patients should be wary of any pills that are different in size, shape, color or markings from their standard medication. A full list of the effected medications can be viewed on the FDA website…
http://www.youtube.com/watch?v=g1HRXYkHE2c The first Yaz trial which was set to begin next week has been postponed in an effort to reach a settlement of the claims. Judge David Herndon has appointed a mediator to work with the parties to reach a settlement. There have been more than 10,000 suites filed in the Multidistrict Litigation.
On December 29, 2011 the Judicial Panel on Multidistrict Litigation (JPML) established MDL No. 2299 for all federal claims alleging injury caused by the diabetes drug Actos. Actos, manufactured by Takeda Pharmaceuticals America Inc., is the tenth best-selling medication in the U.S. and has been found to increase the risk of developing bladder cancer in…
The FDA has renewed a warning about the potential for dosing errors with liquid acetaminophen products for infants. FDA advisory committees made recommendations in 2009 that all liquid acetaminophen be produced in a single concentration: 160mg/5mL. The recommendation was voluntary and not all manufacturers have followed it so there are still products with strengths of…
A recent study showed Multaq doubled the risk of heart-related complications in patients with permanent atrial fibrillation. The study, conducted bythe drugmaker, Sanofi, showed higher rates of heart attack, stroke and death in certain patients. While the FDA did not remove Multaq from the market, they recommended restricting the use of the drug to patients…
The Food and Drug Administration last week posted a warning on its website against homeopathic products containing the hormone human chorionic gonadotropin (hCG) that are used for weight loss with severe 500-calories-per-day dieting. The agency also notes that a 500-calorie-a-day diet poses a variety of health risks, including malnutrition, gallstones, electrolyte imbalance and irregular heartbeat.…
NBC Nightly News (12/8, story 7, 2:20, Williams) reported, “Medical experts have been taking…[a] look at Drospirenone/Ethinyl Estradiol [Yaz], because of studies that show they may be more likely to cause dangerous blood clots than older versions of the” medication. Chief Medical Editor Dr. Nancy Snyderman said, “Two of the most popular birth control” medications…
Over the counter weight loss products containing human chorionic gonadotropin (HCG) have been declared fraudulent and illegal by the FDA and the Federal Trade Commission. The agencies have told seven manufacturers to stop selling them. The warning letters sent t manufacturers note that HCG has not received FDA approval for any weight-loss indication. It has…
Research suggesting that the newer birth control formulations are more likely to cause blood clots that the older drugs has prompted the Food and Drug Administration to consider new safety measures. Yaz, Yasmin and other pills containing a synthetic hormone called drospirenone as well as the Ortho Evra patch which uses the hormone norelgestromin are…
In September, The FDA’s Reproductive Health Drugs Advisory Committee and the Drug safety and Risk Management Advisory Committee held a joint meeting to discuss the appropriate duration of use for Fosamax and other bisphosphonates. Earlier this year the FDA required manufacturers to include language in their labels stating that the optimal duration for patient use…